GB9917386D0 - Chemical compounds-II - Google Patents

Chemical compounds-II

Info

Publication number
GB9917386D0
GB9917386D0 GBGB9917386.6A GB9917386A GB9917386D0 GB 9917386 D0 GB9917386 D0 GB 9917386D0 GB 9917386 A GB9917386 A GB 9917386A GB 9917386 D0 GB9917386 D0 GB 9917386D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917386.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Cerebrus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Ltd filed Critical Cerebrus Ltd
Priority to GBGB9917386.6A priority Critical patent/GB9917386D0/en
Publication of GB9917386D0 publication Critical patent/GB9917386D0/en
Priority to PCT/GB2000/002841 priority patent/WO2001007023A2/fr
Priority to AU60080/00A priority patent/AU6008000A/en
Priority to EP00946208A priority patent/EP1212054A2/fr
Priority to JP2001511909A priority patent/JP2003505414A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9917386.6A 1999-07-23 1999-07-23 Chemical compounds-II Ceased GB9917386D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9917386.6A GB9917386D0 (en) 1999-07-23 1999-07-23 Chemical compounds-II
PCT/GB2000/002841 WO2001007023A2 (fr) 1999-07-23 2000-07-21 Composes chimiques - ii
AU60080/00A AU6008000A (en) 1999-07-23 2000-07-21 Chemical compounds-ii
EP00946208A EP1212054A2 (fr) 1999-07-23 2000-07-21 Composes chimiques - ii
JP2001511909A JP2003505414A (ja) 1999-07-23 2000-07-21 Ｃｎａおよび眼疾患におけるアゼチジン化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917386.6A GB9917386D0 (en) 1999-07-23 1999-07-23 Chemical compounds-II

Publications (1)

Publication Number Publication Date
GB9917386D0 true GB9917386D0 (en) 1999-09-22

Family

ID=10857864

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9917386.6A Ceased GB9917386D0 (en) 1999-07-23 1999-07-23 Chemical compounds-II

Country Status (5)

Country Link
EP (1) EP1212054A2 (fr)
JP (1) JP2003505414A (fr)
AU (1) AU6008000A (fr)
GB (1) GB9917386D0 (fr)
WO (1) WO2001007023A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398449T1 (de) * 2003-05-01 2008-07-15 Vernalis Res Ltd Verwendung von azetidincarboxamidderivaten in therapie
US7504522B2 (en) * 2003-05-01 2009-03-17 Vernalis Research Limited Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
JP2006525299A (ja) * 2003-05-01 2006-11-09 ヴァーナリス リサーチ リミテッド アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用
US11141404B1 (en) 2020-11-18 2021-10-12 Anebulo Pharmaceuticals, Inc. Formulations and methods for treating acute cannabinoid overdose
AU2022362107A1 (en) 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226861A (en) * 1978-04-18 1980-10-07 A. H. Robins Company, Inc. N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
IL68699A (en) * 1982-08-19 1986-08-31 Robins Co Inc A H 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
US4505907A (en) * 1982-09-02 1985-03-19 A. H. Robins Company, Inc. N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
FI87559C (fi) * 1985-02-28 1993-01-25 Robins Co Inc A H Foerfarande foer framstaellning av aktiva 3-fenyloxiazetidinkarboxamider
US5095014A (en) * 1990-12-07 1992-03-10 A. H. Robins Company, Incorporated 3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity
US5183903A (en) * 1991-11-26 1993-02-02 A. H. Robins Company, Incorporated Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides
GB9801501D0 (en) * 1998-01-23 1998-03-18 Cerebrus Ltd Chemical compounds - II
PT1049672E (pt) * 1998-01-23 2004-02-27 Vernalis Res Ltd Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
GB9917385D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-I

Also Published As

Publication number Publication date
WO2001007023A2 (fr) 2001-02-01
EP1212054A2 (fr) 2002-06-12
JP2003505414A (ja) 2003-02-12
WO2001007023A3 (fr) 2001-05-25
AU6008000A (en) 2001-02-13

Similar Documents

Publication Publication Date Title
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
GB9903861D0 (en) Chemical compounds
GB9910104D0 (en) Chemical compounds
GB9910110D0 (en) Chemical compounds
GB9917386D0 (en) Chemical compounds-II
GB9917385D0 (en) Chemical compounds-I
GB9900078D0 (en) Chemical compounds
GB9917384D0 (en) Chemical compounds-III
GB9910394D0 (en) Chemical compounds
GB9910793D0 (en) Chemical processes
GB9908355D0 (en) Chemical compounds
GB9910419D0 (en) Chemical compounds
GB9925837D0 (en) Chemical compounds -III
GB9925838D0 (en) Chemical compounds -II
GB9925839D0 (en) Chemical Compounds -I
GB9909582D0 (en) Chemical compounds
GB9901844D0 (en) Chemical compounds
GB9910405D0 (en) Chemical compounds
GB9910409D0 (en) Chemical compounds
GB9910417D0 (en) Chemical compounds
GB9909668D0 (en) Chemical compounds
GB9910421D0 (en) Chemical compounds
GB9909442D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)